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a  b  s  t  r  a  c  t
The  present  paper  proposes  an  analytical  method  for  fast  near-infrared  (NIR)  determination  of  dipyrone
in  injectable  formulations  with  a  nominal  content  of  50.0%  m v−1 without  violation  of  the  ampoule.  For
this  purpose,  two  multivariate  calibration  methods  are  evaluated,  namely  Partial-Least-Squares  (PLS)
and Multiple  Linear  Regression  (MLR)  with  variable  selection  by  the  Successive  Projections  Algorithm
(SPA).  The  resulting  models  comprised  four  latent  variables  (PLS)  and  ﬁve  spectral  variables  (MLR-SPA).






(MLR-SPA)  and  correlation  coefﬁcients  of 0.9970  (PLS)  and  0.9975  (MLR-SPA)  for  a calibration  range  of
40–60% m  v−1.  No  systematic  error  was  observed  and  no  signiﬁcant  differences  were  found  between  the
predicted  and  reference  values,  according  to a  paired  t-test  at 95%  conﬁdence  level.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.. Introduction
Dipyrone (metamizole sodium; (sodium [(2,3-dihydro-1,5-
imethyl-3-oxo-2-phenyl-1H-pyrazole-4-yl) methylamine]
ethanesulfonate) is an analgesic and antipyretic drug with
eripheral, central and anti-inﬂammatory actions related to the
nhibition of the cyclooxygenase enzyme system (COX-1 and
OX-2) [1].  Sodium dipyrone in injectable form is routinely used in
ospital practice and postoperative care in Brazil and other coun-
ries. The injectable formulation has the advantage of providing
aster therapeutic effects when compared to other delivery forms,
s the active principle is directly deployed in the bloodstream [2].
owever, quality control is a major concern, which motivates the
evelopment of fast, low-cost, and selective methods for routine
nalysis.
Iodometric titration is indicated in the Brazilian pharmacopeia
s the ofﬁcial method for determination of dipyrone in injectable
ormulations [3].  This method involves a time-consuming chemi-
al reaction, which must be carried out at a controlled temperature
elow 15 ◦C. An additional difﬁculty is related to the instability
f the iodine solution. These inconveniences have motivated the
evelopment of methods based on instrumental techniques, such
s spectrophotometry [4],  ﬂuorimetry [5],  electrochemistry [6],
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Open access under the Elsevier OA license.chemiluminescence [7] and high performance liquid chromatog-
raphy (HPLC) [8].  However, such methods still generate chemical
waste and require the violation of the sample ampoule, which must
be subsequently discarded. To overcome these drawbacks, near-
infrared (NIR) spectrometry may  be an advantageous alternative.
NIR spectrometry has been employed in several applications to
carry out fast and non-destructive analyses without the need for
sample treatment or chemical reagents [9,10].  Within the scope
of pharmaceutical applications, NIR spectrometry has been widely
used for determination of quality parameters in drug samples. Most
investigations in this ﬁeld have been concerned with solid formu-
lations [11,12], although some works have also dealt with creams
[13] and injectables [14]. An interesting feature of NIR spectrome-
try consists of the possibility of carrying out non-invasive analyses
of drug samples in closed packages, such as powders in USP vials
[15]. A recent study reported the discrimination of genuine and
counterfeit samples of injectable dexamethasone on the basis of
NIR spectra measured through the closed ampoules [16].
However, the application of NIR spectrometry for quantitative
analysis of injectable drugs in closed ampoules still merits investi-
gation. In this context, the present paper proposes a novel analytical
method for fast and accurate determination of sodium dipyrone
without violation of the ampoule. For this purpose, NIR spectrom-
etry is employed with two  multivariate calibration techniques,
namely Partial Least Squares (PLS) [17] and Multiple Linear Regres-
sion (MLR) with variable selection by the Successive Projections
Algorithm (MLR-SPA) [18–20].
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. Experimental
.1. Samples
The investigation involved a total of 1340 commercial ampoules
rom 71 different batches with nominal value of 50.0% m v−1 of
odium dipyrone. Chemical analysis reports with actual sodium
ipyrone content were provided by the manufacturers, following
he iodometric titration method indicated in the Brazilian pharma-
opeia [3].  In addition, 15 synthetic samples with concentrations
0.0, 44.0, 44.5, 45.0, 45.5, 46.0, 48.0, 50.0, 52.0, 54.0, 54.5, 55.0,
5.5, 56.0, 60.0% m v−1 were prepared in the laboratory by dis-
olving sodium dipyrone (analytical grade) in water for injectable
reparations. This range of concentrations is in agreement with the
ecommendation of the European Medicines Agency for the Eval-
ation of Medicinal Products (EMEA) [21], which states that the
alibration interval should extend from 80% to 120% of the label
laim (50.0% m v−1 in the present case). This range also comprises
he interval of concentrations accepted by the Brazilian National
ealth Authority, namely 45.0–55.0% m v−1 [3].
.2. Spectrum acquisition
The sample spectra were acquired by using an FT-NIR spec-
rophotometer (Perkin Elmer, Spectrum GX). A lab-made teﬂon
older (Fig. 1) was used to support the ampoules in the spec-
rophotometer sample compartment. The external diameter of the
mpoules was approximately 1 cm.  Each spectrum was  obtained as
he average of 16 scans in the range 9110–8200 cm−1 with a resolu-
ion of 1 cm−1. Temperature and relative humidity were controlled
round 26 ◦C and 45%, respectively.
In order to account for small manufacturing differences among
he ampoules, four different ampoules were used as cells for
ecording the spectra of the 15 synthetic samples. Therefore, 60
pectra were obtained. The spectra of the commercial samples were
cquired with the original closed ampoules. The blank spectrum
as obtained by using water for injectable preparations. Each spec-
rum was acquired in triplicate and the average was  then used in the
ubsequent stages of the study. Moreover, the spectra of all sam-
les of the same batch were coaveraged. The resulting 131 spectra
60 for the synthetic samples and 71 for the commercial samples)
re shown in Fig. 2a.
.3. Chemometric procedures and softwareA Savitzky–Golay derivative ﬁlter (second-order polynomial
nd 81-point window) was employed to eliminate undesirable
aseline features in the NIR spectra. The resulting derivative
Fig. 1. NIR spectrophotometer with the lab-made teﬂon holder which was usedFig. 2. (a) Raw and (b) derivative NIR absorbance spectra.
spectra, which are presented in Fig. 2b, comprised 831 variables. In
addition, the variables were mean-centered before the modeling
procedures.
The sample set was divided into calibration (65), validation
(33) and prediction (33) subsets by applying the SPXY (sample
set partitioning based on joint x–y distances) algorithm [22] to
the derivative spectra. The calibration and validation samples were
used in the model-building process. The prediction samples were
only employed in the ﬁnal evaluation and comparison of the result-
ing models.
PLS regression was carried out in the Unscrambler® X.1 soft-
ware (CAMO S.A.), whereas data pre-treatment and MLR-SPA were
implemented in Matlab 2010b (Mathworks). The MLR-SPA routine
was  implemented as described elsewhere [18]. The validation set
was  employed to guide the selection of latent variables in PLS and
the individual spectral variables in MLR-SPA. The default settings
of the computational routines were employed throughout.
The resulting models were compared in terms of the root-
mean-square error (RMSEP) and correlation coefﬁcient (rpred) in
the prediction set.3. Results and discussion
Fig. 3a and b present the plots of predicted versus reference
values of dipyrone concentration for PLS (4 latent variables) and
 to support the ampoules in the spectrophotometer sample compartment.
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Fig. 3. Predicted versus reference plots obtained with: (a) PLS (full-spectrum) and
(b)  MLR-SPA models for determination of sodium dipyrone in the calibration (),



































[Fig. 4. Mean NIR spectrum with wavenumbers selected by MLR-SPA.
LR-SPA (5 spectral variables), respectively. As can be seen, there
s good agreement between predicted and reference values over the
alibration, validation and prediction sets. Moreover, no systematic
rror is present, as the points are distributed on both sides of the
isectrix line along the entire range of y-values.
In terms of performance metrics for the prediction set, appropri-
te results were obtained by using either PLS (RMSEP = 0.39% m v−1,
pred = 0.9970) or MLR-SPA (RMSEP = 0.35% m v−1, rpred = 0.9975).
oreover, in both cases, a paired t-test for the prediction set did
ot indicate signiﬁcant differences between the predicted and ref-
rence values at 95% conﬁdence level. These results suggest that the
roposed analytical method is a suitable strategy for determination
f dipyrone in closed ampoules.
Finally, it is worth noting that an F-test at 95% conﬁdence level
id not indicate signiﬁcant RMSEP differences between the PLS
nd MLR-SPA models. However, the possibility of obtaining suit-
ble results by using a small number of variables in MLR-SPA (ﬁve
ariables, as illustrated in Fig. 4), offers good perspectives for the
esign of dedicated, less costly equipment employing LEDs in the
IR range [23,24].
. ConclusionThe present paper proposed a fast and accurate analytical
ethod for determination of sodium dipyrone in injectable for-
ulations without violation of the ampoule. For this purpose,
IR spectrometry was employed and two multivariate calibration
[
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methods (PLS and MLR-SPA) were evaluated. Appropriate pre-
dictions were obtained, with RMSEP values of 0.39 (PLS) and
0.35% m v−1 (MLR-SPA), which can be deemed small in view of the
calibration range (40–60% m v−1). The good agreement between
predicted and reference values for dipyrone concentration is also
corroborated by the high correlation coefﬁcients observed in the
PLS (0.9970) and MLR-SPA (0.9975) results. Furthermore, in both
cases no systematic error was observed and no signiﬁcant differ-
ences were found between the predicted and reference values,
according to a paired t-test at 95% conﬁdence level.
Although the prediction performance of MLR-SPA was  not sig-
niﬁcantly superior to PLS, the possibility of obtaining suitable
results by using few spectral variables (ﬁve in this case) may  be
useful for other reasons. The variable selection result could be used,
for instance, to guide the design of dedicated, less costly equipment
for use in routine analyses.
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